{
    "Trade/Device Name(s)": [
        "Stratus\u00ae CS D-Dimer Assay",
        "Stratus\u00ae CS D-Dimer (DDMR) Assay"
    ],
    "Submitter Information": "Dade Behring Inc.",
    "510(k) Number": "K051597",
    "Predicate Device Reference 510(k) Number(s)": [
        "K022976"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DAP"
    ],
    "Summary Letter Date": "August 17, 2005",
    "Summary Letter Received Date": "June 16, 2005",
    "Submission Date": "June 15, 2005",
    "Regulation Number(s)": [
        "21 CFR 864.7320"
    ],
    "Regulation Name(s)": [
        "Fibrinogen/fibrin degradation products assay"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "D-dimer",
        "Fibrin degradation products"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube",
        "Heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Stratus\u00ae CS STAT fluorometric analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Sandwich immunoassay",
        "Radial Partition Immunoassay (RPIA)",
        "Fluorometric measurement"
    ],
    "Methodologies": [
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Stratus\u00ae CS D-Dimer Assay using immunoassay and RPIA technology for quantitative measurement of D-dimer in plasma",
    "Indications for Use Summary": "Quantitative measurement of cross-linked fibrin degradation products (D-dimer) in human citrated or heparinized plasma to aid in the diagnosis of venous thromboembolism (VTE) including deep vein thrombosis (DVT) or pulmonary embolism (PE)",
    "fda_folder": "Hematology"
}